Altimmune Z Score


USD 9.09  0.22  2.36%   

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Please continue to Altimmune Piotroski F Score and Altimmune Valuation analysis.
Altimmune Invested Capital Average is comparatively stable at the moment as compared to the past year. Altimmune reported Invested Capital Average of 45.09 Million in 2021. Market Capitalization is likely to gain to about 392.7 M in 2022, whereas Invested Capital is likely to drop (2.2 M) in 2022. Altimmune Gross Profit is comparatively stable at the moment as compared to the past year. Altimmune reported Gross Profit of 4.41 Million in 2021. Interest Expense is likely to gain to 5,805 in 2022, whereas Net Income is likely to drop (99.6 M) in 2022.

Altimmune Z Score Analysis

Altimmune's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Z Score 
Sum Of  
5 Factors 
More About Z Score | All Equity Analysis
First Factor
1.2 * (
Working Capital
Total Assets )
Second Factor
1.4 * (
Retained Earnings
Total Assets )
Thrid Factor
3.3 * (
Total Assets )
Fouth Factor
0.6 * (
Market Value of Equity
Total Liabilities )
Fifth Factor
0.99 * (
Total Assets )

Altimmune Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Altimmune is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Altimmune's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Altimmune's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Altimmune's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

In accordance with the company's disclosures, Altimmune has a Z Score of 0.0. This is 100.0% lower than that of the iShares sector and 100.0% lower than that of the Market Neutral industry. The z score for all United States stocks is 100.0% higher than that of the company.

Altimmune Current Valuation Drivers

We derive many important indicators used in calculating different scores of Altimmune from analyzing Altimmune's financial statements. These drivers represent accounts that assess Altimmune's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Altimmune's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(1.55 M)(1.45 M)(820.8 K)(1.14 M)(2.07 M)(2.12 M)
Revenue Per Employee357.94 K382.64 K232.06 K189.83 K93.84 K96.31 K
Average Assets62.24 M55.15 M59.45 M158.72 M244.32 M263.61 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(51.87 M)(45.03 M)(21.18 M)(54.52 M)(96.89 M)(99.44 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(51.76 M)(44.72 M)(20.19 M)(54.02 M)(96.53 M)(99.07 M)
Earnings before Tax(52.06 M)(45.32 M)(20.58 M)(54.46 M)(97.09 M)(99.65 M)
Average Equity45.56 M41.09 M52.61 M136.75 M224.03 M241.72 M
Enterprise Value14.64 M11.5 M18.09 M229.51 M189.11 M151.82 M
Free Cash Flow(20.37 M)(10.39 M)(9.6 M)(34.51 M)(90.36 M)(92.73 M)
Invested Capital8.21 M2.09 M28.41 M104.32 M(2.17 M)(2.22 M)
Invested Capital Average4.58 M3.32 M16.28 M54.88 M45.09 M48.65 M
Market Capitalization31.15 M18.04 M28.99 M373.04 M364.01 M392.74 M
Tangible Asset Value24.31 M40.9 M41.33 M232.29 M206.45 M222.74 M
Working Capital19.63 M34.84 M35.47 M218.24 M185.85 M200.52 M

Altimmune Institutional Holders

Institutional Holdings refers to the ownership stake in Altimmune that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Altimmune's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Altimmune's value.
Security TypeSharesValue
Xtx Topco LtdCommon Shares19.7 K120 K
Xtx Topco LtdCommon Shares14.8 K135 K
Woodline Partners LpCommon Shares550.7 K6.4 M
Woodline Partners LpCommon Shares846.6 K5.2 M
Woodline Partners LpCommon Shares620.7 K5.7 M
Woodline Partners LpCommon Shares348.8 K3.9 M
Wolverine Trading LlcCommon Shares24.1 K284 K
Wolverine Trading LlcCall Options29.8 K351 K
Wolverine Trading LlcPut Options41.6 K371 K

Fund Asset Allocation for Altimmune

The fund invests 21.57% of asset under management in tradable equity instruments, with the rest of investments concentrated in bonds (15.26%) and various exotic instruments.
       Instrument Type  

Altimmune Fundamentals

About Altimmune Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Altimmune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Altimmune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Altimmune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. Altimmune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Altimmune without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Recommendations Now


Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Pair Trading with Altimmune

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Altimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altimmune will appreciate offsetting losses from the drop in the long position's value.

Moving together with Altimmune

+0.65EMSKFMUSK METALS CORP Earnings Call  This WeekPairCorr

Moving against Altimmune

-0.77PILBFPilbara Minerals Downward RallyPairCorr
-0.66SGMLSigma Lithium Corp Buyout TrendPairCorr
The ability to find closely correlated positions to Altimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Altimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Altimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Altimmune to buy it.
The correlation of Altimmune is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Altimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Altimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Altimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Altimmune Piotroski F Score and Altimmune Valuation analysis. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for analysis

When running Altimmune price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Altimmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
441.4 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine Altimmune value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.